事後緊急避孕藥的全球市場 2023-2027
市場調查報告書
商品編碼
1184152

事後緊急避孕藥的全球市場 2023-2027

Global Emergency Contraceptive Pills Market 2023-2027

出版日期: | 出版商: TechNavio | 英文 154 Pages | 訂單完成後即時交付

價格

事後緊急避孕藥的市場規模在2022年~2027年間,預測將成長到2億5,870萬美元的增加,預測期間預計將以年複合成長率4.83%增長。

本報告提供事後緊急避孕藥市場整體分析,提供市場規模·預測,趨勢,成長促進因素·課題,網羅了約25家供應商的供應商分析。

同時本報告還提供當前全球市場趨勢與推動因素以及整體市場環境的最新分析。市場成長的主要因素有意識改革配合措施數的增加,計劃外妊娠的增加,線上購買的容易度等。

目錄

第1章 摘要整理

  • 市場概要

第2章 市場形勢

  • 市場生態系統

第3章 市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模 2022
  • 市場預測:2022-2027年的預測

第4章 市場規模實際成果

  • 全球事後緊急避孕藥市場2017年-2021年
  • 流通管道市場區隔分析2017-2021
  • 類型市場區隔分析2017-2021
  • 地區市場區隔分析2017-2021
  • 國家市場區隔分析2017-2021

第5章 波特的五力分析

  • 五力的摘要
  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情況

第6章 各流通管道市場區隔

  • 市場·市場區隔
  • 各流通管道比較
  • 零售店 - 市場規模與預測 2022-2027
  • 網路商店 - 市場規模與預測 2022-2027
  • 各流通管道的市場機會

第7章 各類型的市場區隔

  • 市場·市場區隔
  • 各類型比較
  • 組合藥丸 - 市場規模與預測 2022-2027
  • 孕酮錠劑 - 市場規模與預測 2022-2027
  • 各類型的市場機會

第8章 客戶形勢

  • 客戶形勢概要

第9章 各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美 - 市場規模與預測 2022-2027
  • 歐洲 - 市場規模與預測 2022-2027
  • 亞洲 - 市場規模與預測 2022-2027
  • 其他地區(ROW) - 市場規模與預測 2022-2027
  • 美國 - 市場規模與預測 2022-2027
  • 中國 - 市場規模與預測 2022-2027
  • 德國 - 市場規模與預測 2022-2027
  • 法國 - 市場規模與預測 2022-2027
  • 日本 - 市場規模與預測 2022-2027
  • 各地區形勢的市場機會

第10章 促進因素,課題,及趨勢

  • 推動市場要素
  • 市場課題
  • 推動因素與課題的影響
  • 市場趨勢

第11章 業者情勢

  • 概要
  • 業者情勢
  • 混亂狀況
  • 產業的風險

第12章 供應商分析

  • 交易廠商
  • 供應商的市場定位
  • AbbVie Inc.
  • Afaxys Pharma LLC
  • Bayer AG
  • Combe Inc.
  • Foundation Consumer Healthcare LLC
  • Gedeon Richter Plc
  • HLL Lifecare Ltd.
  • Laboratoire HRA Pharma SAS
  • Lupin Ltd.
  • Mankind Pharma Ltd.
  • Perrigo Co. Plc
  • Pfizer Inc.
  • Piramal Enterprises Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Syzygy Healthcare LLC

第13章 附錄

Product Code: IRTNTR70846

Technavio has been monitoring the emergency contraceptive pills market and is forecast to grow by $258.7 mn during 2022-2027, accelerating at a CAGR of 4.83% during the forecast period. Our report on the emergency contraceptive pills market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in number of initiatives to create awareness, increase in unplanned pregnancies, and ease of online purchase.

Technavio's emergency contraceptive pills market is segmented as below:

By Distribution Channel

  • Retail stores
  • Online stores

By Type

  • Combination pills
  • Progesterone pills

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the importance of family planning as one of the prime reasons driving the emergency contraceptive pills market growth during the next few years. Also, the advent of online apps and rising disposable income will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the emergency contraceptive pills market covers the following areas:

  • Emergency contraceptive pills market sizing
  • Emergency contraceptive pills market forecast
  • Emergency contraceptive pills market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading emergency contraceptive pills market vendors that include AbbVie Inc., Afaxys Pharma LLC, Bayer AG, Combe Inc., Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Ltd., Knoll Healthcare Pvt. Ltd., Laboratoire HRA Pharma SAS, Lupin Ltd., Mankind Pharma Ltd., Morepen Laboratories Ltd., Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., Syzygy Healthcare LLC, and Teva Pharmaceutical Industries Ltd. Also, the emergency contraceptive pills market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global emergency contraceptive pills market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on Global emergency contraceptive pills market 2017 - 2021 ($ million)
  • 4.2 Distribution channel Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
  • 4.3 Type Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel

  • 6.1 Market segments
  • Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
  • 6.2 Comparison by Distribution Channel
  • Exhibit 32: Chart on Comparison by Distribution Channel
  • Exhibit 33: Data Table on Comparison by Distribution Channel
  • 6.3 Retail stores - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Retail stores - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Retail stores - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Retail stores - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Retail stores - Year-over-year growth 2022-2027 (%)
  • 6.4 Online stores - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Online stores - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Online stores - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Online stores - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Online stores - Year-over-year growth 2022-2027 (%)
  • 6.5 Market opportunity by Distribution Channel
  • Exhibit 42: Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Type

  • 7.1 Market segments
  • Exhibit 43: Chart on Type - Market share 2022-2027 (%)
  • Exhibit 44: Data Table on Type - Market share 2022-2027 (%)
  • 7.2 Comparison by Type
  • Exhibit 45: Chart on Comparison by Type
  • Exhibit 46: Data Table on Comparison by Type
  • 7.3 Combination pills - Market size and forecast 2022-2027
  • Exhibit 47: Chart on Combination pills - Market size and forecast 2022-2027 ($ million)
  • Exhibit 48: Data Table on Combination pills - Market size and forecast 2022-2027 ($ million)
  • Exhibit 49: Chart on Combination pills - Year-over-year growth 2022-2027 (%)
  • Exhibit 50: Data Table on Combination pills - Year-over-year growth 2022-2027 (%)
  • 7.4 Progesterone pills - Market size and forecast 2022-2027
  • Exhibit 51: Chart on Progesterone pills - Market size and forecast 2022-2027 ($ million)
  • Exhibit 52: Data Table on Progesterone pills - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Chart on Progesterone pills - Year-over-year growth 2022-2027 (%)
  • Exhibit 54: Data Table on Progesterone pills - Year-over-year growth 2022-2027 (%)
  • 7.5 Market opportunity by Type
  • Exhibit 55: Market opportunity by Type ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 59: Chart on Geographic comparison
  • Exhibit 60: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 China - Market size and forecast 2022-2027
  • Exhibit 81: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 82: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 83: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 84: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.9 Germany - Market size and forecast 2022-2027
  • Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.10 France - Market size and forecast 2022-2027
  • Exhibit 89: Chart on France - Market size and forecast 2022-2027 ($ million)
  • Exhibit 90: Data Table on France - Market size and forecast 2022-2027 ($ million)
  • Exhibit 91: Chart on France - Year-over-year growth 2022-2027 (%)
  • Exhibit 92: Data Table on France - Year-over-year growth 2022-2027 (%)
  • 9.11 Japan - Market size and forecast 2022-2027
  • Exhibit 93: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 94: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 95: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibit 96: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 97: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 98: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 100: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 101: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 102: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 103: Matrix on vendor position and classification
  • 12.3 AbbVie Inc.
  • Exhibit 104: AbbVie Inc. - Overview
  • Exhibit 105: AbbVie Inc. - Product / Service
  • Exhibit 106: AbbVie Inc. - Key news
  • Exhibit 107: AbbVie Inc. - Key offerings
  • 12.4 Afaxys Pharma LLC
  • Exhibit 108: Afaxys Pharma LLC - Overview
  • Exhibit 109: Afaxys Pharma LLC - Product / Service
  • Exhibit 110: Afaxys Pharma LLC - Key offerings
  • 12.5 Bayer AG
  • Exhibit 111: Bayer AG - Overview
  • Exhibit 112: Bayer AG - Business segments
  • Exhibit 113: Bayer AG - Key news
  • Exhibit 114: Bayer AG - Key offerings
  • Exhibit 115: Bayer AG - Segment focus
  • 12.6 Combe Inc.
  • Exhibit 116: Combe Inc. - Overview
  • Exhibit 117: Combe Inc. - Product / Service
  • Exhibit 118: Combe Inc. - Key offerings
  • 12.7 Foundation Consumer Healthcare LLC
  • Exhibit 119: Foundation Consumer Healthcare LLC - Overview
  • Exhibit 120: Foundation Consumer Healthcare LLC - Product / Service
  • Exhibit 121: Foundation Consumer Healthcare LLC - Key offerings
  • 12.8 Gedeon Richter Plc
  • Exhibit 122: Gedeon Richter Plc - Overview
  • Exhibit 123: Gedeon Richter Plc - Business segments
  • Exhibit 124: Gedeon Richter Plc - Key news
  • Exhibit 125: Gedeon Richter Plc - Key offerings
  • Exhibit 126: Gedeon Richter Plc - Segment focus
  • 12.9 HLL Lifecare Ltd.
  • Exhibit 127: HLL Lifecare Ltd. - Overview
  • Exhibit 128: HLL Lifecare Ltd. - Product / Service
  • Exhibit 129: HLL Lifecare Ltd. - Key offerings
  • 12.10 Laboratoire HRA Pharma SAS
  • Exhibit 130: Laboratoire HRA Pharma SAS - Overview
  • Exhibit 131: Laboratoire HRA Pharma SAS - Product / Service
  • Exhibit 132: Laboratoire HRA Pharma SAS - Key offerings
  • 12.11 Lupin Ltd.
  • Exhibit 133: Lupin Ltd. - Overview
  • Exhibit 134: Lupin Ltd. - Product / Service
  • Exhibit 135: Lupin Ltd. - Key news
  • Exhibit 136: Lupin Ltd. - Key offerings
  • 12.12 Mankind Pharma Ltd.
  • Exhibit 137: Mankind Pharma Ltd. - Overview
  • Exhibit 138: Mankind Pharma Ltd. - Product / Service
  • Exhibit 139: Mankind Pharma Ltd. - Key offerings
  • 12.13 Perrigo Co. Plc
  • Exhibit 140: Perrigo Co. Plc - Overview
  • Exhibit 141: Perrigo Co. Plc - Business segments
  • Exhibit 142: Perrigo Co. Plc - Key news
  • Exhibit 143: Perrigo Co. Plc - Key offerings
  • Exhibit 144: Perrigo Co. Plc - Segment focus
  • 12.14 Pfizer Inc.
  • Exhibit 145: Pfizer Inc. - Overview
  • Exhibit 146: Pfizer Inc. - Product / Service
  • Exhibit 147: Pfizer Inc. - Key news
  • Exhibit 148: Pfizer Inc. - Key offerings
  • 12.15 Piramal Enterprises Ltd.
  • Exhibit 149: Piramal Enterprises Ltd. - Overview
  • Exhibit 150: Piramal Enterprises Ltd. - Business segments
  • Exhibit 151: Piramal Enterprises Ltd. - Key offerings
  • Exhibit 152: Piramal Enterprises Ltd. - Segment focus
  • 12.16 Sun Pharmaceutical Industries Ltd.
  • Exhibit 153: Sun Pharmaceutical Industries Ltd. - Overview
  • Exhibit 154: Sun Pharmaceutical Industries Ltd. - Product / Service
  • Exhibit 155: Sun Pharmaceutical Industries Ltd. - Key offerings
  • 12.17 Syzygy Healthcare LLC
  • Exhibit 156: Syzygy Healthcare LLC - Overview
  • Exhibit 157: Syzygy Healthcare LLC - Product / Service
  • Exhibit 158: Syzygy Healthcare LLC - Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 159: Inclusions checklist
  • Exhibit 160: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 161: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 162: Research methodology
  • Exhibit 163: Validation techniques employed for market sizing
  • Exhibit 164: Information sources
  • 13.5 List of abbreviations
  • Exhibit 165: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on Global emergency contraceptive pills market 2017 - 2021 ($ million)
  • Exhibits19: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
  • Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
  • Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by Distribution Channel
  • Exhibits33: Data Table on Comparison by Distribution Channel
  • Exhibits34: Chart on Retail stores - Market size and forecast 2022-2027 ($ million)
  • Exhibits35: Data Table on Retail stores - Market size and forecast 2022-2027 ($ million)
  • Exhibits36: Chart on Retail stores - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Retail stores - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Online stores - Market size and forecast 2022-2027 ($ million)
  • Exhibits39: Data Table on Online stores - Market size and forecast 2022-2027 ($ million)
  • Exhibits40: Chart on Online stores - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Online stores - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Market opportunity by Distribution Channel ($ million)
  • Exhibits43: Chart on Type - Market share 2022-2027 (%)
  • Exhibits44: Data Table on Type - Market share 2022-2027 (%)
  • Exhibits45: Chart on Comparison by Type
  • Exhibits46: Data Table on Comparison by Type
  • Exhibits47: Chart on Combination pills - Market size and forecast 2022-2027 ($ million)
  • Exhibits48: Data Table on Combination pills - Market size and forecast 2022-2027 ($ million)
  • Exhibits49: Chart on Combination pills - Year-over-year growth 2022-2027 (%)
  • Exhibits50: Data Table on Combination pills - Year-over-year growth 2022-2027 (%)
  • Exhibits51: Chart on Progesterone pills - Market size and forecast 2022-2027 ($ million)
  • Exhibits52: Data Table on Progesterone pills - Market size and forecast 2022-2027 ($ million)
  • Exhibits53: Chart on Progesterone pills - Year-over-year growth 2022-2027 (%)
  • Exhibits54: Data Table on Progesterone pills - Year-over-year growth 2022-2027 (%)
  • Exhibits55: Market opportunity by Type ($ million)
  • Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits57: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits59: Chart on Geographic comparison
  • Exhibits60: Data Table on Geographic comparison
  • Exhibits61: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits63: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits64: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits67: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits71: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits77: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits78: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits79: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits80: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits81: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits82: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits83: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits84: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits87: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits89: Chart on France - Market size and forecast 2022-2027 ($ million)
  • Exhibits90: Data Table on France - Market size and forecast 2022-2027 ($ million)
  • Exhibits91: Chart on France - Year-over-year growth 2022-2027 (%)
  • Exhibits92: Data Table on France - Year-over-year growth 2022-2027 (%)
  • Exhibits93: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibits94: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibits95: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits96: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibits97: Market opportunity By Geographical Landscape ($ million)
  • Exhibits98: Impact of drivers and challenges in 2022 and 2027
  • Exhibits99: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits100: Overview on factors of disruption
  • Exhibits101: Impact of key risks on business
  • Exhibits102: Vendors covered
  • Exhibits103: Matrix on vendor position and classification
  • Exhibits104: AbbVie Inc. - Overview
  • Exhibits105: AbbVie Inc. - Product / Service
  • Exhibits106: AbbVie Inc. - Key news
  • Exhibits107: AbbVie Inc. - Key offerings
  • Exhibits108: Afaxys Pharma LLC - Overview
  • Exhibits109: Afaxys Pharma LLC - Product / Service
  • Exhibits110: Afaxys Pharma LLC - Key offerings
  • Exhibits111: Bayer AG - Overview
  • Exhibits112: Bayer AG - Business segments
  • Exhibits113: Bayer AG - Key news
  • Exhibits114: Bayer AG - Key offerings
  • Exhibits115: Bayer AG - Segment focus
  • Exhibits116: Combe Inc. - Overview
  • Exhibits117: Combe Inc. - Product / Service
  • Exhibits118: Combe Inc. - Key offerings
  • Exhibits119: Foundation Consumer Healthcare LLC - Overview
  • Exhibits120: Foundation Consumer Healthcare LLC - Product / Service
  • Exhibits121: Foundation Consumer Healthcare LLC - Key offerings
  • Exhibits122: Gedeon Richter Plc - Overview
  • Exhibits123: Gedeon Richter Plc - Business segments
  • Exhibits124: Gedeon Richter Plc - Key news
  • Exhibits125: Gedeon Richter Plc - Key offerings
  • Exhibits126: Gedeon Richter Plc - Segment focus
  • Exhibits127: HLL Lifecare Ltd. - Overview
  • Exhibits128: HLL Lifecare Ltd. - Product / Service
  • Exhibits129: HLL Lifecare Ltd. - Key offerings
  • Exhibits130: Laboratoire HRA Pharma SAS - Overview
  • Exhibits131: Laboratoire HRA Pharma SAS - Product / Service
  • Exhibits132: Laboratoire HRA Pharma SAS - Key offerings
  • Exhibits133: Lupin Ltd. - Overview
  • Exhibits134: Lupin Ltd. - Product / Service
  • Exhibits135: Lupin Ltd. - Key news
  • Exhibits136: Lupin Ltd. - Key offerings
  • Exhibits137: Mankind Pharma Ltd. - Overview
  • Exhibits138: Mankind Pharma Ltd. - Product / Service
  • Exhibits139: Mankind Pharma Ltd. - Key offerings
  • Exhibits140: Perrigo Co. Plc - Overview
  • Exhibits141: Perrigo Co. Plc - Business segments
  • Exhibits142: Perrigo Co. Plc - Key news
  • Exhibits143: Perrigo Co. Plc - Key offerings
  • Exhibits144: Perrigo Co. Plc - Segment focus
  • Exhibits145: Pfizer Inc. - Overview
  • Exhibits146: Pfizer Inc. - Product / Service
  • Exhibits147: Pfizer Inc. - Key news
  • Exhibits148: Pfizer Inc. - Key offerings
  • Exhibits149: Piramal Enterprises Ltd. - Overview
  • Exhibits150: Piramal Enterprises Ltd. - Business segments
  • Exhibits151: Piramal Enterprises Ltd. - Key offerings
  • Exhibits152: Piramal Enterprises Ltd. - Segment focus
  • Exhibits153: Sun Pharmaceutical Industries Ltd. - Overview
  • Exhibits154: Sun Pharmaceutical Industries Ltd. - Product / Service
  • Exhibits155: Sun Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits156: Syzygy Healthcare LLC - Overview
  • Exhibits157: Syzygy Healthcare LLC - Product / Service
  • Exhibits158: Syzygy Healthcare LLC - Key offerings
  • Exhibits159: Inclusions checklist
  • Exhibits160: Exclusions checklist
  • Exhibits161: Currency conversion rates for US$
  • Exhibits162: Research methodology
  • Exhibits163: Validation techniques employed for market sizing
  • Exhibits164: Information sources
  • Exhibits165: List of abbreviations